Our results show that the experimental combination is increasing the activity of SOD in the cortex and catalase and GPx activity in the hippocampus, which together with its demonstrated AChE-inhibiting ability is setting it as an attractive candidate in the prevention and treatment of cognitive (age) decline and AD. This evidence concerns the gene CAT and Alzheimer disease.